rs201171029
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000257.4(MYH7):c.5361A>G(p.Glu1787Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0002 in 1,614,248 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000257.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000859 AC: 216AN: 251488Hom.: 3 AF XY: 0.000508 AC XY: 69AN XY: 135920
GnomAD4 exome AF: 0.000213 AC: 311AN: 1461890Hom.: 4 Cov.: 34 AF XY: 0.000151 AC XY: 110AN XY: 727246
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152358Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74510
ClinVar
Submissions by phenotype
not specified Benign:4
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Glu1787Glu in exon 37 of MYH7: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. This variant is listed in dbSNP and 1000 geno mes with a frequency of 7.6% (10/132) in the Mexican American population (rs2011 71029). Glu1787Glu in exon 37 of MYH7 (rs201171029; allele frequency = 7.6, 10 /132) -
- -
not provided Benign:3
- -
- -
- -
Cardiomyopathy Benign:2
- -
- -
Hypertrophic cardiomyopathy Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at